Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Mercurius Iodatus Ruber
Brand Name
Mercurius Iodatus Ruber
Generic Name
Mercurius Iodatus Ruber
Active Ingredient
MercuricCategory
Standardized Insect Venom Allergenic Extract [EPC]
Salt Form
Chloride
Variants
8
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 1 [hp_Q]/1 | PELLET | ORAL | 37662-2445 |
| 200 [hp_C]/1 | PELLET | ORAL | 37662-2442 |
| 100 [hp_C]/1 | PELLET | ORAL | 37662-2441 |
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Mercurius Iodatus Ruber, you must consult a qualified healthcare professional.
| 500 [hp_C]/1 | PELLET | ORAL | 37662-2443 |
| 6 [hp_C]/1 | PELLET | ORAL | 37662-2438 |
| 30 [hp_C]/1 | PELLET | ORAL | 37662-2440 |
| 12 [hp_C]/1 | PELLET | ORAL | 37662-2439 |
| 1 [hp_M]/1 | PELLET | ORAL | 37662-2444 |
Detailed information about Mercurius Iodatus Ruber
Mercuric (as Mercuric Chloride) is a specialized compound utilized primarily as a standardized chemical allergen for diagnostic testing. It belongs to the class of Standardized Chemical Allergen [EPC] and requires strict clinical oversight due to its potent pharmacological profile.
For diagnostic purposes, such as patch testing for allergic contact dermatitis, the dosage of Mercuric is highly standardized. The typical concentration used is 0.1% Mercuric Chloride in petrolatum. A very small amount (usually 20 microliters or a small 'ribbon' of paste) is applied to a specialized testing chamber (such as a Finn Chamber) and placed on the patient's back. This is not a medication taken daily, but a single-exposure diagnostic event.
In historical contexts or rare industrial scenarios where other forms might be used, the dosage is strictly calculated based on the specific salt form and the intended diagnostic outcome. There is no 'standard' oral or injectable dose for Mercuric in modern medicine due to its extreme toxicity.
Mercuric is generally not recommended for use in children unless the clinical necessity for allergy testing outweighs the risks and no safer alternative is available. If used, the procedure must be performed by a pediatric allergist or dermatologist. Standard pediatric dosing for patch testing has not been established by the FDA, and extreme caution is advised to prevent accidental ingestion or excessive skin absorption in smaller patients.
Mercuric is highly nephrotoxic (toxic to the kidneys). In patients with pre-existing renal impairment (CKD, Stage 3 or higher), even diagnostic patch testing should be approached with caution. While topical absorption is low, the kidneys are the primary site of mercury accumulation. No specific dose adjustment exists for topical testing, but systemic use is contraindicated.
While the liver is not the primary site of Mercuric toxicity compared to the kidneys, patients with severe hepatic failure may have altered protein binding, which could theoretically affect the systemic distribution of any absorbed mercuric ions.
Elderly patients often have a physiological decline in GFR (Glomerular Filtration Rate). Healthcare providers must monitor for signs of systemic sensitivity more closely in this population, as their ability to clear heavy metals may be reduced.
Mercuric is never self-administered. It is applied by a healthcare professional during a clinical visit.
In the context of diagnostic testing, a 'missed dose' refers to a patch that has fallen off or a missed follow-up appointment for reading the results. If the patch detaches early, the test is usually invalidated and must be repeated after the skin has fully recovered. If you miss your follow-up appointment, the results may be inaccurate, as allergic reactions can peak and then fade.
An overdose of Mercuric (particularly Mercuric Chloride) is a medical emergency.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to use any mercuric-containing product without medical guidance.
When used as a diagnostic allergen, the most common side effects are localized to the site of application. Because the purpose of the test is to elicit a reaction in sensitive individuals, these 'side effects' are often the expected clinical outcome:
These symptoms typically resolve within a few days to a week after the patch is removed.
Mercuric is a substance of high clinical concern due to its potential for systemic toxicity. It must only be used by trained medical professionals in a controlled setting. Patients must be screened for pre-existing mercury sensitivity before the application of any diagnostic patch. If you have ever had a severe reaction to dental fillings, certain older vaccines, or industrial chemicals, you must inform your doctor.
No FDA black box warnings for Mercuric. However, regulatory bodies emphasize that Mercuric compounds are not for therapeutic use and carry a high risk of morbidity if misused.
Mercuric should not be used in combination with certain substances that can exacerbate its toxicity or interfere with its diagnostic accuracy:
Mercuric must NEVER be used in the following circumstances:
Mercuric is generally classified as Pregnancy Category X (or D, depending on the specific regulatory context). Mercury is a potent neurodevelopmental toxin. It can cross the placenta and accumulate in fetal tissues, particularly the developing brain. Exposure during pregnancy is associated with a range of developmental delays and neurological abnormalities. Diagnostic testing with Mercuric should be postponed until after delivery.
Inorganic mercuric ions can be excreted in breast milk. While the amount absorbed from a single diagnostic patch test is likely to be very small, the potential for accumulation in the nursing infant exists. Healthcare providers typically recommend postponing elective allergy testing while breastfeeding, or pausing breastfeeding for a period if testing is absolutely necessary.
Mercuric is not FDA-approved for routine use in infants or young children. The risk of systemic toxicity is higher in children due to their thinner skin and smaller body volume. If testing is required for a child with suspected severe contact dermatitis, it must be performed under the strict supervision of a specialist using the lowest possible concentration.
Mercuric (as Mercuric Chloride) acts as a Standardized Chemical Allergen by forming hapten-protein complexes. The mercuric ion (Hg2+) is too small to be recognized by the immune system on its own. Instead, it binds covalently to skin proteins (haptens). These 'modified' proteins are then processed by Langerhans cells (skin-resident immune cells) and presented to T-cells, triggering a Type IV delayed hypersensitivity reaction.
Systemically, its role as an Acetylcholine Release Inhibitor involves the blockade of voltage-gated calcium channels at nerve terminals. By preventing the influx of calcium, it stops the fusion of synaptic vesicles with the membrane, thereby inhibiting the release of acetylcholine into the synaptic cleft. This leads to neuromuscular weakness and autonomic dysfunction.
The pharmacodynamic effect of Mercuric in allergy testing is delayed, typically peaking 48 to 72 hours after exposure. The dose-response relationship is steep; very low concentrations (0.1%) are sufficient to trigger a reaction in sensitized individuals, while higher concentrations can cause non-specific irritant reactions or tissue necrosis in anyone.
Common questions about Mercurius Iodatus Ruber
In modern clinical practice, Mercuric (specifically Mercuric Chloride) is primarily used as a diagnostic tool in patch testing. It helps healthcare providers identify if a patient has an allergy to mercury, which can be found in industrial settings, dental amalgams, or certain older preservatives. When applied to the skin in a controlled manner, it triggers a localized reaction in sensitive individuals. This allows for the diagnosis of allergic contact dermatitis. It is not used as a treatment for any disease, but rather as a way to confirm a specific chemical sensitivity.
The most common side effects are localized to the site where the Mercuric patch was applied. Patients typically experience redness, itching, and small raised bumps (papules) on the skin. In more significant reactions, small blisters (vesicles) may form. These symptoms are actually the intended 'positive' result of the diagnostic test. They usually appear within 48 to 72 hours and resolve within a week after the patch is removed. If the reaction spreads beyond the test site, you should contact your doctor.
While there is no direct chemical interaction between topical Mercuric and alcohol, it is generally advised to limit alcohol consumption during the 48 to 96 hours of diagnostic testing. Alcohol can cause skin flushing and vasodilation, which might make the test site more itchy or uncomfortable. Furthermore, alcohol could potentially interfere with your body's ability to manage a strong allergic reaction. Always follow the specific lifestyle instructions provided by your allergist. If you experience systemic symptoms, avoid alcohol entirely and seek medical advice.
No, Mercuric is not considered safe during pregnancy. Mercury is a known developmental toxin that can cross the placenta and affect the growth and neurological development of the fetus. Even the small amount used in a diagnostic skin patch carries a theoretical risk that is generally considered unacceptable in elective situations. Most doctors will recommend waiting until after you have given birth and finished breastfeeding before undergoing mercury allergy testing. If you discover you are pregnant after the test has started, notify your doctor immediately to have the patch removed.
As a diagnostic allergen, Mercuric works through a delayed hypersensitivity reaction. This means the skin response does not happen immediately. It typically takes 48 hours for the first signs of a reaction to appear, which is why the patches are usually left on for two days. A second 'reading' is often done at 72 or 96 hours because some reactions take longer to peak. If you are looking for a 'quick' result, it is important to understand that the immune system needs this time to process the allergen and mount a visible response.
Mercuric is not a daily medication, so 'stopping' it simply involves removing the diagnostic patch. If you experience severe pain, burning, or systemic symptoms like dizziness or shortness of breath, the patch should be removed immediately. You should not wait for your scheduled appointment if you are having an adverse reaction. However, you should contact your healthcare provider as soon as you remove it so they can document the reaction and provide further instructions. Washing the area with mild soap and water can help remove any remaining residue.
In the context of Mercuric testing, a 'missed dose' usually means a patch has fallen off or you missed your follow-up appointment. If the patch falls off before the 48-hour mark, do not try to tape it back on yourself; the test is likely invalidated. Contact your doctor to reschedule the test for a later date. If you miss the appointment to have the results read, the test may need to be repeated, as the skin reaction can change rapidly after the 96-hour window. Accuracy depends on precise timing.
There is no evidence that the diagnostic use of Mercuric causes weight gain. Because it is applied topically in a very small amount for a short period, it does not affect the metabolic or endocrine systems responsible for weight regulation. However, chronic systemic mercury poisoning (which is a different and much more serious condition) can cause a variety of systemic symptoms, but weight gain is not a typical feature. If you notice sudden weight changes, they are likely due to other factors and should be discussed with your primary care physician.
Mercuric patch testing can be affected by other medications, particularly those that suppress the immune system. If you are taking oral steroids (like prednisone), immunosuppressants, or using strong steroid creams on your back, the test may give a false-negative result. You must inform your doctor about all your current medications before the test begins. Most specialists will ask you to stop using topical steroids in the test area for at least two weeks. It is generally safe to continue most other systemic medications, but always confirm with your doctor.
Mercuric Chloride is a basic chemical compound and is not 'branded' in the way that modern prescription drugs are. It is produced by various chemical and pharmaceutical supply companies as a reagent-grade substance. In the clinical setting, it is provided as part of standardized allergen kits (like the T.R.U.E. Test or similar diagnostic series). There is no 'brand name' version of Mercuric Chloride for patient use, as it is strictly a professional-use diagnostic agent. Its availability is limited to specialized allergy and dermatology clinics.
Other drugs with the same active ingredient (Mercuric)
> Warning: Stop the diagnostic process and call your doctor immediately if you experience any of these systemic symptoms after exposure to Mercuric.
Prolonged or repeated exposure to Mercuric (usually in occupational settings) can lead to chronic mercury poisoning. Symptoms include:
No FDA black box warnings currently exist specifically for the diagnostic use of Mercuric Chloride allergenic extracts. However, the substance is widely recognized by the CDC and OSHA as a highly toxic material. The primary warnings associated with Mercuric focus on its status as a potent corrosive and systemic toxin. Clinical labeling emphasizes that it is 'For Diagnostic Use Only' and must not be ingested or applied to large areas of broken skin.
Report any unusual symptoms, especially those occurring away from the site of application, to your healthcare provider immediately.
For standard diagnostic patch testing, intensive lab monitoring is usually not required. However, if systemic absorption is suspected or if a patient has significant pre-existing conditions, the following may be monitored:
Topical application of Mercuric for diagnostic testing does not typically interfere with the ability to drive or operate machinery. However, if a patient experiences a severe systemic reaction or significant discomfort from the test site, they should exercise caution.
There is no direct interaction between topical Mercuric and alcohol. However, alcohol can cause vasodilation (widening of blood vessels), which might theoretically increase the redness or itching at the test site. It is best to avoid excessive alcohol during the 48-96 hour testing window.
In the context of a diagnostic test, 'discontinuation' means removing the patch. If a patient develops an immediate, severe burning sensation or signs of a systemic reaction, the patch must be removed immediately, and the area should be washed thoroughly with water.
> Important: Discuss all your medical conditions, especially kidney or neurological issues, with your healthcare provider before starting Mercuric testing.
Mercuric can interfere with certain laboratory tests that rely on enzymatic reactions, as the mercuric ion is a potent enzyme inhibitor. However, this is primarily a concern in in vitro (laboratory) settings rather than in the patient's blood unless systemic poisoning has occurred.
For each major interaction, the mechanism typically involves:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those applied to the skin.
Conditions requiring careful risk-benefit analysis include:
Patients who are allergic to Mercuric Chloride may also show cross-sensitivity to:
> Important: Your healthcare provider will evaluate your complete medical history, including any previous reactions to dental work or industrial chemicals, before prescribing Mercuric testing.
In older adults, the primary concern is the age-related decline in renal function. Because mercury is cleared by the kidneys, elderly patients may be at a slightly higher risk for systemic accumulation if any absorption occurs. Additionally, the skin of elderly patients may be thinner and more prone to irritation or ulceration at the test site.
Patients with a GFR (Glomerular Filtration Rate) below 30 mL/min should avoid Mercuric exposure. In those with moderate impairment, monitoring for signs of systemic toxicity is essential. Mercuric Chloride is a direct toxin to the proximal tubules of the kidney.
While not a primary contraindication, patients with severe liver disease (Child-Pugh Class C) should be monitored. The liver produces glutathione, which is a key molecule in the body's natural defense against heavy metal toxicity. Reduced glutathione levels in liver disease could theoretically increase sensitivity to mercuric ions.
> Important: Special populations require individualized medical assessment. Always inform your specialist if you are pregnant, planning to become pregnant, or have any history of kidney disease.
| Parameter | Value |
|---|---|
| Bioavailability | <1% (Topical on intact skin); >90% (Oral) |
| Protein Binding | >99% (Primarily to albumin and sulfhydryl groups) |
| Half-life | 30 - 60 days (Systemic) |
| Tmax | 48 - 72 hours (For skin reaction) |
| Metabolism | Non-enzymatic; Redox reactions |
| Excretion | Renal (approx. 50%), Fecal (approx. 50%) |
Mercuric belongs to the Standardized Chemical Allergen [EPC] class. It is grouped with other diagnostic allergens like Nickel Sulfate and Potassium Dichromate. In the broader EPC indexing provided, it is uniquely associated with diverse classes like Nitrogen Binding Agent [EPC] due to its reactivity with nitrogenous groups in biological molecules.